The Europe mHealth Market is expected to witness market growth of 31.1% CAGR during the forecast period (2020-2026).
The prevalence of chronic diseases has risen in Europe over the last decades in line with the aging population, frequently affecting a larger percentage of people of serviceable age. According to the World Health Organization (WHO), more than one-third of the European population over the age of 15 will have a chronic illness, and two out of three individuals at retirement age will have at least two chronic conditions. As a result, the prevalence of chronic diseases is increasing awareness, which has, in effect, generated a need for constant surveillance of health, leading to the introduction of healthcare management devices.
Over the last few years, digitalization has oriented almost all industries, especially healthcare. With the growing proliferation of smartphones and Internet access, the adoption of mHealth technologies by physicians and patients has increased significantly. This is especially true for mobile healthcare applications, including fitness and medical applications, with fitness and wellness having a significant share of the total market for mHealth apps.
The market is driven by the advent of digital healthcare that has gained traction due to US-based mobile health app providers, manufacturers of wearable devices, and e-prescription structures. In addition, because of supporting government initiatives across all regions, the healthcare industry exhibits high growth potential for the IT industry.
Growing innovations in preventive healthcare and increased funding for mHealth start-ups are also driving the market growth. Mobile healthcare applications are gaining momentum in the healthcare sector with the advent of numerous digital start-ups. In addition, the rise in adoption of mHealth is due to factors such as increased penetration of smartphones, high internet use, and the easy availability of mHealth apps.
Based on Type, the market is segmented into Services and Devices. Based on Services, the market is segmented into Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others. Based on Devices, the market is segmented into BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others. Based on Stakeholders, the market is segmented into Mobile Operators, Device Vendors, Healthcare Providers and Content Players. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Medtronic PLC, Johnson and Johnson, Koninklijke Philips N.V., DexCom, Inc., Samsung Electronics Co., Ltd. (Samsung Group), Omron Corporation, AllScripts Healthcare Solutions, Inc., Sanofi S.A., Cerner Corporation.
Scope of the Study
Market Segmentation:
By Type
By Services
By Devices
By Stakeholders
By Country
Companies Profiled:
Unique Offerings from the Publisher:
The prevalence of chronic diseases has risen in Europe over the last decades in line with the aging population, frequently affecting a larger percentage of people of serviceable age. According to the World Health Organization (WHO), more than one-third of the European population over the age of 15 will have a chronic illness, and two out of three individuals at retirement age will have at least two chronic conditions. As a result, the prevalence of chronic diseases is increasing awareness, which has, in effect, generated a need for constant surveillance of health, leading to the introduction of healthcare management devices.
Over the last few years, digitalization has oriented almost all industries, especially healthcare. With the growing proliferation of smartphones and Internet access, the adoption of mHealth technologies by physicians and patients has increased significantly. This is especially true for mobile healthcare applications, including fitness and medical applications, with fitness and wellness having a significant share of the total market for mHealth apps.
The market is driven by the advent of digital healthcare that has gained traction due to US-based mobile health app providers, manufacturers of wearable devices, and e-prescription structures. In addition, because of supporting government initiatives across all regions, the healthcare industry exhibits high growth potential for the IT industry.
Growing innovations in preventive healthcare and increased funding for mHealth start-ups are also driving the market growth. Mobile healthcare applications are gaining momentum in the healthcare sector with the advent of numerous digital start-ups. In addition, the rise in adoption of mHealth is due to factors such as increased penetration of smartphones, high internet use, and the easy availability of mHealth apps.
Based on Type, the market is segmented into Services and Devices. Based on Services, the market is segmented into Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others. Based on Devices, the market is segmented into BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others. Based on Stakeholders, the market is segmented into Mobile Operators, Device Vendors, Healthcare Providers and Content Players. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Medtronic PLC, Johnson and Johnson, Koninklijke Philips N.V., DexCom, Inc., Samsung Electronics Co., Ltd. (Samsung Group), Omron Corporation, AllScripts Healthcare Solutions, Inc., Sanofi S.A., Cerner Corporation.
Scope of the Study
Market Segmentation:
By Type
- Services and
- Devices
By Services
- Monitoring services
- Diagnosis services
- Healthcare Systems Strengthening Services and
- Others
By Devices
- BP Monitors
- Cardiac Monitors
- Pulse Oximetry
- Blood Glucose Meters
- Apnea & Sleep Monitors
- Neurological Monitors
- Wearable Fitness Sensor Device & Heart Rate Meters and
- Others
By Stakeholders
- Mobile Operators
- Device Vendors
- Healthcare Providers and
- By Application
- Cardiovascular Diseases
- Diabetes
- Respiratory
- Neurology and
- Other Applications
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled:
- Bayer AG
- Medtronic PLC
- Johnson and Johnson
- Koninklijke Philips N.V.
- DexCom, Inc.
- Samsung Electronics Co., Ltd. (Samsung Group)
- Omron Corporation
- AllScripts Healthcare Solutions, Inc.
- Sanofi S.A.
- Cerner Corporation
Unique Offerings from the Publisher:
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe mHealth Market by Type
Chapter 5. Europe mHealth Market by Stakeholders
Chapter 6. Europe mHealth Market by Applications
Chapter 7. Europe mHealth Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Bayer AG
- Medtronic PLC
- Johnson and Johnson
- Koninklijke Philips N.V.
- DexCom, Inc.
- Samsung Electronics Co., Ltd. (Samsung Group)
- Omron Corporation
- AllScripts Healthcare Solutions, Inc.
- Sanofi S.A.
- Cerner Corporation
Methodology
LOADING...
